Perinatal pharmacology

Affiliations

¹ Department of Development and Regeneration, KU Leuven and Neonatal Intensive Care Unit, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium.
² Department of Surgery, Section of Neonatal Intensive Care Unit, Puericulture Institute and Neonatal Section, University of Cagliari, Cagliari, Italy.
³ Departments of Pediatrics, Pharmacology, Physiology, and Integrative Systems Biology, George Washington University School of Medicine and Health Sciences, Washington DC, USA ; Intensive Care, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands ; Department of Pediatric Pharmacology, University Children's Hospital Basel, Basel, Switzerland.
⁴ Department of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University of Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany.

Editorial

Karel Allegaert et al. Biomed Res Int. 2014.

. 2014:2014:101620.

doi: 10.1155/2014/101620. Epub 2014 Apr 13.

¹ Department of Development and Regeneration, KU Leuven and Neonatal Intensive Care Unit, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium.
² Department of Surgery, Section of Neonatal Intensive Care Unit, Puericulture Institute and Neonatal Section, University of Cagliari, Cagliari, Italy.
³ Departments of Pediatrics, Pharmacology, Physiology, and Integrative Systems Biology, George Washington University School of Medicine and Health Sciences, Washington DC, USA ; Intensive Care, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands ; Department of Pediatric Pharmacology, University Children's Hospital Basel, Basel, Switzerland.
⁴ Department of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University of Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany.

No abstract available

References

1. Feghali MN, Mattison DR. Clinical therapeutics in pregnancy. Journal of Biomedicine and Biotechnology. 2011;2011:13 pages.783528 - PMC - PubMed
1. Allegaert K, Langhendries JP, van den Anker JN. Educational paper: do we need neonatal clinical pharmacologists? European Journal of Pediatrics. 2013;172(4):429–435. - PMC - PubMed
1. Khalil F, Läer S. Physiologically based pharmacokinetic modeling: methodology, applications, and limitations with a focus on its role in pediatric drug development. Journal of Biomedicine and Biotechnology. 2011;2011:13 pages.907461 - PMC - PubMed
1. de Cock RF, Piana C, Krekels EH, Danhof M, Allegaert K, Knibbe CA. The role of population PK-PD modelling in paediatric clinical research. European Journal of Clinical Pharmacology. 2011;67(1, supplement):5–16. - PMC - PubMed
1. Allegaert K, Smits A, van den Anker J. Physiologically based pharmacokinetic modeling in pediatric drug development: a clinician’s request for a more integrated approach. Journal of Biomedicine and Biotechnology. 2012;2012:3 pages.103763 - PMC - PubMed